For D-Wave, Washington’s $100M Bet on Quantum Comes With Strings Attached

D-Wave stock rallies over 50% after $100M CHIPS Act equity injection, but dilution and $355M net loss raise concerns as bookings surge 2,000%.

Washington’s stamp of approval rarely comes without fine print. D-Wave Quantum discovered that firsthand last week when the Commerce Department pledged $100 million in CHIPS Act funding—structured as an equity investment that will dilute existing shareholders. The market cheered anyway, sending the stock up more than 50% in seven days, but the rally masks a more complicated calculus for a company still burning through cash at a rapid clip.

The preliminary memorandum of terms, signed on May 21, makes D-Wave one of nine quantum computing firms selected to share a $2 billion pool under the CHIPS and Science Act. IBM landed the lion’s share at $1 billion, while Rigetti Computing and Infleqtion both received $100 million alongside D-Wave. The funding is intended to accelerate the development and scaling of D-Wave’s hybrid quantum platform, which combines quantum annealing with gate-model systems.

Unlike a grant or loan, the Commerce Department’s $100 million comes as a direct equity injection. D-Wave will issue common shares to the government once the final agreements are executed—a move that hands the state a stake in the company and waters down the holdings of current investors. That dilution risk has been a central talking point among traders who see the cash as both a lifeline and a drag on future per-share value.

A Rally That Bordered on Parabolic

The market’s initial reaction was unambiguous. Over three trading sessions, the stock surged 66%, before settling into a more measured gain. On a euro-denominated basis, D-Wave closed Friday at €25.04, representing a 52.9% advance for the week. The move pushed the relative strength index to 70.1, a level that signals overbought conditions, and left the stock trading 56.7% above its 50-day moving average and 24.3% above the 200-day line. One-month annualized volatility hit 148%, reflecting the ferocity of the buying spree.

Short sellers are feeling the heat. Short interest stands at 52 million shares, or 14.5% of the float, down 11.5% from the prior period. A squeeze may have added fuel to the rally, but the underlying fundamentals remain a source of debate. The broader quantum sector has been on a tear—IonQ has climbed more than 145% from its March low—and some traders warn that valuations are outstripping commercial reality.

The Revenue Picture: Small, But Bookings Are Exploding

D-Wave’s financials offer a stark contrast to the market’s enthusiasm. Over the trailing twelve months, the company generated just $24.6 million in revenue, with a gross margin of 82.6%. Operating losses ran to $100.4 million, and the net loss deepened to $355.1 million. The first quarter of fiscal 2026 saw revenue dip to $2.9 million, an 81% year-over-year decline.

But the bookings story is dramatically different. Orders surged nearly 2,000% to a record $33.4 million, driven in part by a $10 million quantum-computing-as-a-service contract with a Fortune 100 client. For analysts, that metric is the most telling: it shows that enterprise demand is real, even if it hasn’t yet translated into recurring revenue. Consensus estimates peg full-year revenue at $42 million, a figure that still leaves D-Wave trading at an extreme multiple given its current market capitalization.

Ambitious Roadmap, Thin Commercial Foothold

The CHIPS money is earmarked for R&D facilities in Boca Raton, Florida; New Haven, Connecticut; and Burnaby, British Columbia. D-Wave plans to use the capital to push toward a superconducting annealing system with 100,000 qubits and a dual-rail gate-model system with 10,000 qubits, targeting roughly 100 logical qubits. The company envisions applications in quantum chemistry and energy-efficient artificial intelligence.

Annealing remains the commercially proven leg of the business; gate-model systems won’t become economically viable until physical qubit counts are far higher. The technological ambition is clear, the path to scalable profitability less so.

A Critical Fortnight of Investor Engagement

D-Wave’s management now faces the challenge of translating government backing and record bookings into a credible business narrative. The next two weeks offer multiple stages for that message:

• May 28: TD Cowen conference in New York
• June 1: The company’s first-ever Investor Day at the New York Stock Exchange
• June 3: Baird conference in New York
• June 10: Rosenblatt virtual event
• Mid-June: Qubits-Europe conference in London

The Investor Day on June 1 is the most consequential. D-Wave is expected to detail its technology roadmap, commercial momentum, the impact of its Quantum Circuits acquisition, and its financial strategy. With the stock already pricing in a wave of optimism, the burden is now on the company to show that state support and surging bookings can eventually close the gap between promise and profit.

Analysts remain unanimously bullish: all 13 covering the stock rate it a Buy, with a median price target of $35.17—a range that spans $19.58 to $45. For a stock that has already run hard on speculation, the next few weeks will determine whether the rally has legs or whether dilution and a still-subscale revenue base eventually catch up.